Frequent testing — and the infrastructure to support it — presents an enticing research opportunity for scientists. The partnership allows NBA players, coaches and staff who opt-in to supplement their required testing regimen with an extra step that will help bring SalivaDirect closer to public use. Grubaugh said that their team is preparing to apply for emergency use authorization from the Food and Drug Administration with the goal of making the test ready for public use by as early as mid-July. Comparing saliva test results to those that originate from the NBA’s regular testing will help validate the effectiveness of SalivaDirect.